Gout Patient Resources

What is Gout?National Institute of Arthritis and Musculoskeletal and Skin Diseases

 

GoutMedline Plus (National Institutes of Health

 

GoutJAMA Patient Page

 

GoutAmerican College of Rheumatology

 

GoutArthritis Foundation

 

Gout: Your Orthopedic ConnectionAmerican Academy of Orthopedic Surgeons

 

Related Videos
Esther Ellen Freeman, MD, PhD: How COVID-19 Is Affecting Skin Differently in 2023
Erin Michos, MD, MHS | Courtesy: Johns Hopkins School of Medicine
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
Related Content

Biosimilar MB02-DM Demonstrates Bioequivalence to Bevacizumab

March 23rd 2023

Updates in the Standards of Care in Diabetes in 2023 - Obesity and Weight Management

March 22nd 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

Embracing Research and Finding Support to Manage Type 1 Diabetes

March 21st 2023

Impact of IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients With Plaque Psoriasis, PsA

March 22nd 2023

AHA/ACC Scientific Statement Reports Benefit of Supervised Exercise Training for HFpEF

March 22nd 2023

Biosimilar MB02-DM Demonstrates Bioequivalence to Bevacizumab

March 23rd 2023

Updates in the Standards of Care in Diabetes in 2023 - Obesity and Weight Management

March 22nd 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

Embracing Research and Finding Support to Manage Type 1 Diabetes

March 21st 2023

Impact of IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients With Plaque Psoriasis, PsA

March 22nd 2023

AHA/ACC Scientific Statement Reports Benefit of Supervised Exercise Training for HFpEF

March 22nd 2023

Biosimilar MB02-DM Demonstrates Bioequivalence to Bevacizumab

March 23rd 2023

Updates in the Standards of Care in Diabetes in 2023 - Obesity and Weight Management

March 22nd 2023

Oral Povorcitinib Significantly Improves Total, Facial Vitiligo in 24 Week Trial

March 22nd 2023

Embracing Research and Finding Support to Manage Type 1 Diabetes

March 21st 2023

Impact of IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients With Plaque Psoriasis, PsA

March 22nd 2023

AHA/ACC Scientific Statement Reports Benefit of Supervised Exercise Training for HFpEF

March 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.